You must be 18 or older to view this site.
All products sold by Limitless Peptides are supplied strictly for laboratory and research use. They are not drugs, foods or cosmetics, and are not for human or veterinary consumption.
By entering you confirm you are acquiring these materials for research purposes only.
Price range: $100.00 through $180.00
Triple receptor agonist (GIP/GLP-1/glucagon) studied for advanced metabolic and weight management research.
Out of stock. Leave your email and we will tell you the moment it returns.
One email about this product only. You are not subscribed to anything.
Retatrutide is a triple receptor agonist acting on the GIP, GLP-1, and glucagon receptors. Studied for appetite regulation, glycemic control, and energy expenditure in metabolic research.
| Class | Triple Agonist |
|---|---|
| Receptor Target | GIP + GLP-1 + Glucagon Receptors |
| Composition | Single |
| Molecule Type | Peptide |
| Half-Life | Long-acting |
| Format | Lyophilized Powder |
| Research Area | Weight Management |
| Strength | 10 mg, 20 mg |
NNMT inhibitor studied for cellular metabolism, fat loss support, energy utilization, and body composition improvement.
Growth hormone-releasing factor analogue studied for visceral fat reduction and metabolic modulation.
Dual GIP/GLP-1 receptor agonist studied for metabolic regulation and weight management research.